Ami Bhatt and Jagat Narula discuss the global impact of rheumatic heart disease, its challenges, and ongoing efforts for ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Higher levels of lipoprotein(a) seem to increase the risk of venous thromboembolism (VTE) in premenopausal women as well as those who have passed menopause and are taking hormone replacement therapy, ...
Three countries with different systems achieved similar levels of control, indicating that efforts to lessen CV risk should ...
The Centers for Medicare & Medicaid Services is weighing whether to cover TAVI in asymptomatic severe aortic stenosis, as ...
Twenty years of data from New England highlight geographical challenges, which some say may merit a rethink of STEMI care.
The 2026 dyslipidemia guidelines offer “a chance to save lives at scale.” But statins alone can’t solve the problem.
Absent contraindications, optimal medical therapy for heart failure with preserved ejection fraction (HFpEF) should include a ...
Strait Access Technologies e-mail: info@sat.za.com, a medical technology company developing next-generation cardiovascular ...
Experts hope the FAI score can become the next big tool in personalized risk assessment, though costs remain unknown.
With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.
The data provide context on the ongoing workforce shortage in heart failure, a pipeline puzzle that’s proving hard to solve.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results